SUSTAINED-RELEASE OF A PEPTIDE FROM LIPOSOME FORMULATIONS

被引：0
|
作者：
YAUYOUNG, A [1 ]
LAW, M [1 ]
CHOW, J [1 ]
LIN, JP [1 ]
机构：
[1] LIPOSOME TECHNOL INC,MENLO PK,CA 94025
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1987年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：188 / 188
页数：1
相关论文
共 50 条
  • [21] SCIENTIFIC RATIONALE AND CLINICAL IMPLICATIONS OF SUSTAINED-RELEASE FORMULATIONS
    KELLAWAY, IW
    [J]. BRITISH JOURNAL OF CLINICAL PRACTICE, 1988, 42 (04): : 9 - 13
  • [22] RELATIVE BIOAVAILABILITY OF IMMEDIATE-RELEASE AND SUSTAINED-RELEASE HYDRALAZINE FORMULATIONS
    LUDDEN, TM
    ROTENBERG, KS
    LUDDEN, LK
    SHEPHERD, AMM
    WOODWORTH, JR
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (12) : 1026 - 1032
  • [23] INVIVO EVALUATION OF RAPID RELEASE AND SUSTAINED-RELEASE GELUCIRE CAPSULE FORMULATIONS
    DENNIS, AB
    FARR, SJ
    KELLAWAY, IW
    TAYLOR, G
    DAVIDSON, R
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 65 (1-2) : 85 - 100
  • [24] In Vivo Pharmacokinetics of Injectable, Intravitreal, Sustained-Release Latanoprost Formulations
    White, William
    Hu, Mae
    Huang, Glenn
    Pham, Tan
    Karasina, Faina
    Lee, Aaron
    Gorlina, Maria
    Wong, Vernon
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [25] REEVALUATION OF THE METABOLISM AND EXCRETION OF DIETHYLPROPION IN NONSUSTAINED AND SUSTAINED-RELEASE FORMULATIONS
    BECKETT, AH
    STANOJCIC, M
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (06) : 409 - 415
  • [26] AGING OF SUSTAINED-RELEASE FORMULATIONS OF AMOXICILLIN AND GELUCIRE 64/02
    CHARRO, MBD
    RIAL, IL
    JATO, JLV
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (04) : 473 - 482
  • [27] In vivo characterization of sustained-release formulations of human growth hormone
    Lee, HJ
    Riley, G
    Johnson, O
    Cleland, JL
    Kim, N
    Charnis, M
    Bailey, L
    Duenas, E
    Shahzamani, A
    Marian, M
    Jones, AJS
    Putney, SD
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 281 (03): : 1431 - 1439
  • [28] MEASUREMENT OF ETHYNYLESTRADIOL AND LEVONORGESTREL INCORPORATED INTO SUSTAINED-RELEASE CONTRACEPTIVE FORMULATIONS
    IOHAN, F
    JACKANICZ, T
    MONDER, C
    [J]. CONTRACEPTION, 1985, 32 (06) : 571 - 580
  • [29] Comparative bioavailability of two sustained-release theophylline formulations in the dog
    Mengozzi, G
    Intorre, L
    Bertini, S
    Giorgi, M
    Soldani, G
    [J]. PHARMACOLOGICAL RESEARCH, 1998, 38 (06) : 481 - 485
  • [30] ACUTE OVERDOSE WITH SUSTAINED-RELEASE DRUG FORMULATIONS - PERSPECTIVES IN TREATMENT
    MINOCHA, A
    SPYKER, DA
    [J]. MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1986, 1 (04): : 300 - 307
12345